Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18548798 | 0.86 | TSHR (0.38) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL17085515 | 0.82 | TSHR (0.44) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL7079859 | 0.82 | TSHR (0.44) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL733109 | 0.77 | TSHR (0.50) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL732071 | 0.73 | TSHR (0.46) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL7876608 | 0.73 | TSHR (0.46) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL966870 | 0.73 | TSHR (0.46) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL14415206 | 0.71 | TSHR (0.44) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL14062955 | 0.71 | TSHR (0.44) | TSHRALDH1A1TDP1TP53SMN1; SMN2 | |
| SCHEMBL18697133 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448604-B1 | HYDROGEL TISSUE ADHESIVE FOR MEDICAL USE | ACTAMAX SURGICAL MATERIALS LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-8796242-B2 | Hydrogel tissue adhesive for medical use | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2014-08-05 | — | — | US | disclosed |
| US-8778326-B2 | Hydrogel tissue adhesive for medical use | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-8580951-B2 | Aldehyde-functionalized polysaccharides | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580950-B2 | Aldehyde-functionalized polysaccharides | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580950-B2 | Aldehyde-functionalized polysaccharides | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580950-B2 | Aldehyde-functionalized polysaccharides | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-20130261080-A1 | HYDROGEL TISSUE ADHESIVE FOR MEDICAL USE | ACTAMAX SURGICAL MATERIALS LLC (US) | 2013-10-03 | — | — | US | disclosed |
| US-20120148523-A1 | HYDROGEL TISSUE ADHESIVE FOR MEDICAL USE | ACTAMAX SURGICAL MATERIALS LLC (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120142787-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-07 | — | — | US | disclosed |
| US-20120142787-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-07 | — | — | US | disclosed |
| US-20120142787-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-07 | — | — | US | disclosed |
| EP-2448604-A2 | HYDROGEL TISSUE ADHESIVE FOR MEDICAL USE | Actamax Surgical Materials LLC (US) | 2012-05-09 | — | — | EP | disclosed |
| US-20120004194-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | E. I. DU PONT NEMOURS AND COMPANY (US) | 2012-01-05 | — | — | US | disclosed |
| WO-2011002956-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-01-06 | — | — | WO | disclosed |
| WO-2011002888-A2 | HYDROGEL TISSUE ADHESIVE FOR MEDICAL USE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142787-A1 | ALDEHYDE-FUNCTIONALIZED POLYSACCHARIDES | CD44, ALDH1A2, ALDH1A3 | TSHR 3419/4885ALDH1A1 6/4885TDP1 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.